The study on omega-3 fatty acids had methodological and statistical limitations, potentially masking real benefits in specific subgroups like reduction in myocardial infarction (MI).

“if you look at certain elements of the composite they were strongly benefited 20% I trying to think of there's a 20% reduction in MI that's what sticks in my mind do you think the most important takeaway from that is if you believe that the study had a methodological in achill and statistical significance one would want to move forward is the bigger knock on that study the dose the patient population that was studied or the composite endpoint all of those together can conspire to have a neutral study when you there really are some good effects that are overlooked”